Top 10 at 11: Half year results and legal woes are making news today
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning [more…]
SafeWatch to call time on workplace mental health crisis
Special Report: Proclaimed as the elixir for remote work woes, the Great Return to the Office has instead morphed into mental health misery for workers [more…]
Market Highlights: New record in sight for Bitcoin, and 5 ASX small caps to watch on Thursday
ASX to open lower, tracking Wall Street Fed member sees rate cuts this year as inflation data looms Bitcoin pops to over US$60k, with [more…]
Aura Energy’s FEED study outlines strong economics for proposed Tiris uranium development
Aura Energy’s FEED study has outlined attractive economics for its Tiris uranium project in Mauritania Post-tax NPV and IRR estimated at US$366m and 34% respectively [more…]
What KPMG reckons about fintechs in 2024 and ASX players to watch – Part Two
KPMG says there’s been consolidation and M&A activity among fintechs following tougher economic conditions MoneyMe reports $6 million statutory NPAT for H1 FY24 with loan [more…]
Long Shortz with Raiden Resources: Raiden confident Mt Sholl is a strategic Pilbara asset
Stockhead’s Ashtyn Hiron sits down with Raiden Resources (ASX:RDN) managing director Dusko Ljubojevic to get the short end of the long story on the company’s [more…]
The commodity where prices have become ‘unsustainable’… and it’s not nickel or lithium
Palladium and platinum prices are sitting so low South African miners are cutting thousands of staff in the hope of staying above water Mining analyst [more…]
Manitoba is largely untapped for critical minerals – but these ASX juniors are homing in
Canada’s lithium rush has been on everyone’s radar these past couple of years, especially when WA’s Galaxy Resources (which became Allkem and is now Arcadium [more…]
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs
Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX [more…]
Follow the money: Private investors are going big on commercial property
Private investors were the most active buyers in commercial real estate for the first time in Australia in 2023, according to Knight Frank’s The Wealth [more…]
